Methyltransferase 21A, also known as HSPA lysine methyltransferase, is an enzyme involved in the post-translational modification of proteins through the addition of methyl groups to lysine residues. This enzyme is encoded by the METTL21A gene and belongs to the family of methyltransferases, which play critical roles in various cellular processes, including gene expression regulation, chromatin organization, and protein function modulation.Methyltransferase 21A specifically catalyzes the methylation of lysine residues within the heat shock protein family A (HSPA), including HSPA1, HSPA5, and possibly other related proteins. Heat shock proteins are chaperones involved in protein folding, degradation, and stress response pathways. The methylation of lysine residues within these proteins may impact their stability, localization, and interactions with other cellular components, thereby influencing cellular homeostasis and stress response mechanisms.
The precise biological significance of lysine methylation by methyltransferase 21A is still under investigation. However, emerging evidence suggests potential roles in regulating the function of heat shock proteins, which are essential for cellular survival under stressful conditions such as heat shock, oxidative stress, and proteotoxic stress.Moreover, dysregulation of methyltransferase 21A activity or expression may have implications in various diseases, including cancer, neurodegenerative disorders, and metabolic syndromes. Altered methylation patterns of heat shock proteins could disrupt their functions, leading to cellular dysfunction and disease progression. Understanding the molecular mechanisms and regulatory pathways involving methyltransferase 21A is crucial for elucidating its physiological roles. Further research into its substrate specificity, interaction partners, and cellular functions will provide insights into its significance in health and disease.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
C646 is a histone acetyltransferase (HAT) inhibitor. Inhibition of HAT activity can lead to altered histone acetylation patterns, affecting gene expression, including that of methyltransferase 21A, HSPA lysine. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $148.00 | 4 | |
BIX-01294 is a histone methyltransferase inhibitor. By targeting histone methyltransferases, it can modulate histone methylation, potentially impacting the expression of methyltransferase 21A, HSPA lysine. | ||||||
Epz004777 | 1338466-77-5 | sc-507560 | 100 mg | $575.00 | ||
EPZ004777 is a lysine methyltransferase inhibitor. It specifically targets lysine methyltransferases, potentially inhibiting the activity of methyltransferase 21A, HSPA lysine. | ||||||
GSK343 | 1346704-33-3 | sc-397025 sc-397025A | 5 mg 25 mg | $148.00 $452.00 | 1 | |
GSK343 is a histone lysine methyltransferase inhibitor. It targets histone lysine methyltransferases, potentially influencing histone methylation patterns and the expression of methyltransferase 21A, HSPA lysine. | ||||||
OG-L002 | 1357302-64-7 | sc-478221 | 5 mg | $270.00 | ||
CPI-455 is a histone lysine methyltransferase inhibitor. Its action on histone lysine methyltransferases can lead to changes in histone methylation patterns, potentially affecting the expression of methyltransferase 21A, HSPA lysine. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
BIX-01338 is a histone methyltransferase inhibitor. Its action on histone methyltransferases can lead to changes in histone methylation patterns, potentially affecting the expression of methyltransferase 21A, HSPA lysine. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638B is a G9a/G9a-like protein lysine methyltransferase inhibitor. By inhibiting G9a-like protein lysine methyltransferases, it may affect the expression of methyltransferase 21A, HSPA lysine. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
UNC0646 is a G9a/G9a-like protein lysine methyltransferase inhibitor. Its action on G9a-like protein lysine methyltransferases can lead to changes in histone methylation patterns, potentially affecting the expression of methyltransferase 21A, HSPA lysine. | ||||||